|
|
|
The foundation of insightful planning requires understanding a particular market, the participants,
competitive dynamics, emerging trends, and the influence of different specialties. There are many
additional therapeutic areas where our team has considerable experience. We encourage you to contact
our team to discuss your unique needs and challenges.
Immunology: Immunology is not a single therapeutic area but rather a physiological and pharmacological
approach to disease understanding and management. Rheumatoid arthritis, psoriasis, SLE, multiple
sclerosis, oncology, and inflammatory diseases can frequently share molecular targets, which raises
the question of which indication to pursue first. The challenge is to adopt a planning process that
leverages core skills and assets across therapeutic category boundaries in order to fully exploit
commercial potential.
Orphan Diseases: With small populations but huge unmet needs, can these diseases be commercially attractive?
They are perfect applications for genetic-based tests and personalized medicine. Health Advances' extensive
experience in Gaucher's disease, Pompe's disease, Cystic Fibrosis, Batten's disease, Huntington's disease,
ALS, and many other genetic diseases gives us insight into the special challenges posed by product
development and commercialization.
Cosmetic and Aesthetic Medicine: From Botox to laser surgery including dermal resurfacing, liposuction and alopecia,
we have helped companies develop and launch devices and drugs that require special appreciation for patient involvement.
Reimbursement is uncertain so self-pay considerations may make or break a product. Intense consumer marketing must
supplement professional detailing and an understanding of physician-office economics.
Gastrointestinal Disorders: Unified by physiology but dramatically different in etiology and management,
diseases such as GERD, pancreatic cancer, liver fibrosis and cirrhosis, ulcerative colitis, Crohn's
disease, small bowel obstructions, and peptic ulcers involve a complex combination of diagnostic
modalities, invasive and non-invasive surgery, and drug therapy. Gastroenterologists, the tertiary
care specialists, are often called in to definitively resolve non-specific symptoms that the general
practitioner cannot treat through empirical measures.
|
|
 |
|
|
|
|
|
 learn more
about our work in other clinical areas. |
|
|
|
|
 |
|
|
